An Enhanced Pipeline for Multi-Omic Integration Based on Topological Data Analysis
- 1CNR
Abstract
The advent of high-throughput sequencing technologies has made it essential to employ advanced tools for data integration and interpretation. In this work, we propose to build upon two existing efforts by expanding their scope and applicability to multi-omic data integration through the development of a pipeline that generates a topologically informed ranking of genes to assess gene relevance to disease. Specifically, we exploit topological data analysis, capitalizing on: its graph-based framework, to refine complex interactions characteristic of biological systems; its intrinsic explainability, to enable interpretation of model outputs in terms of biologically meaningful features; its robustness to small input perturbations, to ensure stable results in the presence of noisy data, as omics are. In particular, we employ Harmonic Persistent Homology (HPH), and propose two relevant advances. First, we adopt an integration and clustering tool (i.e. iNETgrate) as an informed means to reduce data size and integrate multiple omic layers by aggregating methylation beta values from loci to the gene level, to be combined with gene expression values. This enables the application of HPH, otherwise limited by the computational burden. Second, as a non-trivial consequence, we apply HPH to multi-omic molecular data, and not to patients as done so far, enlarging HPH scope. Finally, we follow up on recent efforts toward performance standardization, and validate our results against biomarkers from a well-known TCGA breast cancer benchmark dataset.
Related
- Sparse Machine Learning Pipeline with Stabl Identifies Cord Blood Multi-Omic Signatures of Bronchopulmonary Dysplasia
- fastACCORD enables ultrahigh-dimensional partial correlation modeling for multi-omic data integration
- Multi-omic data integration improves the resolution of the molecular etiology of autism in a mouse model
- BCell-Epitope-Prediction: A local, reproducible pipeline for multi-epitope vaccine design: integration and structural validation against a panel of PDB antigen-antibody complexes
- From mice to humans: A multi-omic predictive framework for translational immunology
BibTeX
@misc{paparozzi2026enhanced,
title = {{An Enhanced Pipeline for Multi-Omic Integration Based on Topological Data Analysis}},
author = {V. Paparozzi and A. Plaksienko and M. Pedicini and C. Nardini},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.21.752955},
url = {https://www.biorxiv.org/content/10.64898/2026.09.21.752955v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - An Enhanced Pipeline for Multi-Omic Integration Based on Topological Data Analysis
AU - V. Paparozzi
AU - A. Plaksienko
AU - M. Pedicini
AU - C. Nardini
PY - 2026
DA - 2026/09/21
PB - bioRxiv
DO - 10.64898/2026.09.21.752955
UR - https://www.biorxiv.org/content/10.64898/2026.09.21.752955v1
AB - The advent of high-throughput sequencing technologies has made it essential to employ advanced tools for data integration and interpretation. In this work, we propose to build upon two existing efforts by expanding their scope and applicability to multi-omic data integration through the development of a pipeline that generates a topologically informed ranking of genes to assess gene relevance to disease. Specifically, we exploit topological data analysis, capitalizing on: its graph-based framework, to refine complex interactions characteristic of biological systems; its intrinsic explainability, to enable interpretation of model outputs in terms of biologically meaningful features; its robustness to small input perturbations, to ensure stable results in the presence of noisy data, as omics are. In particular, we employ Harmonic Persistent Homology (HPH), and propose two relevant advances. First, we adopt an integration and clustering tool (i.e. iNETgrate) as an informed means to reduce data size and integrate multiple omic layers by aggregating methylation beta values from loci to the gene level, to be combined with gene expression values. This enables the application of HPH, otherwise limited by the computational burden. Second, as a non-trivial consequence, we apply HPH to multi-omic molecular data, and not to patients as done so far, enlarging HPH scope. Finally, we follow up on recent efforts toward performance standardization, and validate our results against biomarkers from a well-known TCGA breast cancer benchmark dataset.
ER -